← Evidence map

ArticleStem cells (Dayton, Ohio)2012

Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts.

Caihua Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

this papercites it

Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts. | OpenQuestion